Point72 Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Point72 Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-502,500	Closed	-$73.8M	–	905
2014 Q4	$57.8M	Buy	502,500 +352,500	+235%	+$42.7M	0.41%	68
2014 Q3	$23.4M	Sell	150,000 -377,800	-72%	-$54.8M	0.18%	159
2014 Q2	$65.1M	Buy	+527,800	New	+$58.3M	0.42%	55

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Point72 Asset Management's SLXP Position: Q1 2015 in Review

Point72 Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 502,500 shares — an estimated $73.8M sold.

Point72 Asset Management first reported a position in SLXP in Q2 2014 and held it in 3 quarters. The position peaked at $65.1M in Q2 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Point72 Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Point72 Asset Management sold 502,500 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $73.8M.
Point72 Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 3 quarters.
Point72 Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $65.1M in Q2 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Point72 Asset Management's 13F filing for Q1 2015, filed 15 May 2015.